original ) (raw )Beta 2 Microglobulin as a Marker of Diagnosis and Disease Severity in Non Hodgkin Lymphoma
Krishna Malik
2015
View PDFchevron_right
The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma
Maria Angelopoulou
Haematologica, 2002
View PDFchevron_right
Prognostic Significance of Serum Beta-2 Microglobulin in Patients with Non-Hodgkin Lymphoma
Hualiang Lin
View PDFchevron_right
Clinical significance of serum beta-2 microglobulin levels in hematological malignancies
Quang Huynh
The KITAKANTO Medical Journal, 1997
View PDFchevron_right
Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumours
James Child
Journal of Clinical Pathology, 1987
View PDFchevron_right
Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma
Leticia Rodríguez
Hematological Oncology, 2006
View PDFchevron_right
Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients
ANASTASIA KOPSAFTOPOULOU
Cancers, 2024
View PDFchevron_right
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease
Richard Wilder
Cancer, 2002
View PDFchevron_right
Serum ß 2 -microglobulin levels at diagnosis and during antitumour treatment in children with malignant neoplasms
Ewa Bien
Nowotwory, 2005
View PDFchevron_right
β2-Microglobulin in Chronic Lymphocytic Leukaemia
L. Wibell
Scandinavian Journal of Haematology, 1980
View PDFchevron_right
Alteration of serum beta 2-microglobulin in oral carcinoma
Wilma Silvia
Indian journal of clinical biochemistry : IJCB, 2002
View PDFchevron_right
Production of β2-microglobulin by chronic lymphocytic leukaemia cells in vitro
L. Wibell
Scandinavian Journal of Haematology, 2009
View PDFchevron_right
Correlation and Prognostic Value of Serum Soluble ICAM-1, Beta-2 Microglobulin, and IL-2αR Levels in Non-Hodgkin's Lymphoma
M. Perez-encinas
Leukemia & Lymphoma, 1999
View PDFchevron_right
Prognostic relevance of serum β β2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study
Francesco Merli
2000
View PDFchevron_right
Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma
Jin-Sook Ryu
BLOOD RESEARCH, 2019
View PDFchevron_right
Evaluation of serum β 2 -microglobulin in oral cancer
Wasif Manzar
Australian Dental Journal, 1992
View PDFchevron_right
Estimation of serum β2-microglobulin in potentially malignant disorders and squamous cell carcinoma of the oral cavity: A clinicopathological study
Narendra Gyan Singh
Dental research journal, 2014
View PDFchevron_right
Beta 2 -microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate
Julio Delgado
British Journal of Haematology, 2009
View PDFchevron_right
Beta-2 microglobulin and lactate dehydrogenase levels are useful prognostic markers in early stage primary gastric lymphoma
Byron Narvaez
Clinical and Laboratory Haematology, 1998
View PDFchevron_right
Estimation of Serum Beta 2-Microglobulin Levels in Individuals Exposed to Carcinogens: Clinical Study in Indian Population
Rohan Gupta
Journal of Maxillofacial and Oral Surgery, 2016
View PDFchevron_right
Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis
C. Källander
Scandinavian journal of haematology, 1984
View PDFchevron_right
Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma
Edward Laane , Hele Everaus
Cytometry Part B: Clinical Cytometry, 2005
View PDFchevron_right
Beta2 microglobulin in multiple myeloma
Herbert Fritsche
American Journal of Hematology, 1985
View PDFchevron_right
Relevance of some serum biomarkers (E cadherin, GAGs & MDA in patients with diffuse large B-cell lymphoma
Laila Eissa
Pakistan journal of pharmaceutical sciences, 2008
View PDFchevron_right
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas
Silvia Hernández
Cancers
View PDFchevron_right
Serum Soluble Interleukin-2 Receptor, Beta2-Microglobulin, Lactate Dehydrogenase and Erythrocyte Sedimentation Rate in Children with Hodgkin’s Lymphoma
Ewa Bien
Scandinavian Journal of Immunology, 2009
View PDFchevron_right
Beta-2-Microglobulin Is an Independent Predictor of Progression in Asymptomatic Multiple Myeloma BACKGROUND: Although serum beta-2 microglobulin (B2M) represents a key variable for symptomatic multiple myeloma
Marco Fangazio
View PDFchevron_right
Evaluation of intra‐and interobserver agreement and its clinical significance for scoring bcl‐2 immunohistochemical expression in diffuse large B‐cell lymphoma
Irene Biasoli
Pathology …, 2008
View PDFchevron_right
Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma
Lorenzo de Paoli
Cancer, 2010
View PDFchevron_right
Evaluation of Some Biochemical Markers as Prognostic Factors in Malignant Lymphomas
Laila Eissa
2006
View PDFchevron_right
Quantitation of beta2-Microglobulin and HLA on the Surface of Human Cells
Hans Wigzell
Scandinavian Journal of Immunology, 1977
View PDFchevron_right